News
California energy officials are walking a political tightrope, defending some of their climate rules while conceding others ...
Analysts have recently evaluated Tempus AI and provided 12-month price targets. The average target is $67.88, accompanied by a high estimate of $70.00 and a low estimate of $60.00. Observing a 7.75% ...
4d
Zacks Investment Research on MSNTEM vs. GH: Which AI in Precision Oncology Stock Has More Upside Now?Tempus AI TEM and Guardant Health GH are two dominant players in the field of AI-powered precision oncology. Tempus, newly ...
Whether you’re aiming for a STEM degree in the US or a management course in Germany, understanding the total cost of ...
A number of brokerages recently issued reports on TEM. Morgan Stanley boosted their price objective on Tempus AI from $60.00 to $65.00 and gave the company an “overweight” rating in a research ...
Find out the top grocery items that shrunk in size without you even knowing about it, meaning you're getting less for your ...
The Soundpeats Air5 Pro earbuds are just $79 from Amazon U.S. and £79 from Amazon U.K.. This makes them some of the cheapest ...
We came across a bullish thesis on Tempus AI, Inc. on Make Money, Make Time’s Substack by Oliver | MMMT Wealth. In this ...
Whether you prefer a less ubiquitous design, or you want an option with a more secure fit, we've rounded up the best AirPods alternatives.
NeuroScientific Biopharmaceuticals has acquired unlisted Perth-based Isopogen for $5.1 million, gaining control of the ...
Europe's metal producers are warning of a shortage of scrap and an upending of carbon-emission strategies after U.S. Donald ...
Medeze Group, a leader in Southeast Asia stem cell storage and services market, announced plans to acquire a 10% stake in Cordlife, or 25.63 million shares on May 13, for 25 cents per share.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results